Primary Site >> Liver Cancer
Gene >> NEK2
| 1. | |||||||||||
| Journal: | Gut. 2009 May;58(5):679-87. | ||||||||||
| Title: | Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. | ||||||||||
| Author: | Calvisi, D F|Pinna, F|Ladu, S|Pellegrino, R|Simile, M M|Frau, M|De Miglio, M R|Tomasi, M L|Sanna, V|Muroni, M R|Feo, F|Pascale, R M | ||||||||||
| PMID: | 19136513 | ||||||||||
| 2. | |||||||||||
| Journal: | PLoS One. 2012;7(4):e35510. | ||||||||||
| Title: | Functional and topological properties in hepatocellular carcinoma transcriptome. | ||||||||||
| Author: | Drozdov, Ignat|Bornschein, Jan|Wex, Thomas|Valeyev, Najl V|Tsoka, Sophia|Malfertheiner, Peter | ||||||||||
| PMID: | 22539975 | ||||||||||
| 3. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2014 Jan 9;33:6. | ||||||||||
| Title: | Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1. | ||||||||||
| Author: | Huang, Lynn Y L|Lee, Ying-Shuan|Huang, Jiann-Jyh|Chang, Chia-chi|Chang, Jia-Ming|Chuang, Shih-Hsien|Kao, Kuo-Jang|Tsai, Yung-Jen|Tsai, Pei-Yi|Liu, Chia-Wei|Lin, Her-Sheng|Lau, Johnson Y N | ||||||||||
| PMID: | 24401611 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2014 Sep;74(3):511-20. | ||||||||||
| Title: | Inhibition of Hec1 as a novel approach for treatment of primary liver cancer. | ||||||||||
| Author: | Huang, Lynn Y L|Chang, Chia-chi|Lee, Ying-Shuan|Huang, Jiann-Jyh|Chuang, Shih-Hsien|Chang, Jia-Ming|Kao, Kuo-Jang|Lau, Gillian M G|Tsai, Pei-Yi|Liu, Chia-wei|Lin, Her-Sheng|Gish, Robert G|Lau, Johnson Y N | ||||||||||
| PMID: | 25038613 | ||||||||||
| 5. | |||||||||||
| Journal: | J Gastroenterol Hepatol. 2016 Jan;31(1):256-64. | ||||||||||
| Title: | Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation. | ||||||||||
| Author: | Wubetu, Gizachew Y|Shimada, Mitsuo|Morine, Yuji|Ikemoto, Tetsuya|Ishikawa, Daichi|Iwahashi, Shuichi|Yamada, Shinichiro|Saito, Yu|Arakawa, Yusuke|Imura, Satoru | ||||||||||
| PMID: | 26241688 | ||||||||||
| 6. | |||||||||||
| Journal: | Tumour Biol. 2016 Feb;37(2):2023-35. | ||||||||||
| Title: | Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway. | ||||||||||
| Author: | Zhang, Mei-Xia|Xu, Xi-Ming|Zhang, Peng|Han, Na-Na|Deng, Jun-Jian|Yu, Ting-Ting|Gan, Yuan-Yuan|He, Xiao-Qin|Long, Zhi-Xiong | ||||||||||
| PMID: | 26337275 | ||||||||||
| 7. | |||||||||||
| Journal: | Anticancer Res. 2016 Feb;36(2):757-62. | ||||||||||
| Title: | High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy. | ||||||||||
| Author: | Wubetu, Gizachew Yismaw|Morine, Yuji|Teraoku, Hiroki|Yoshikawa, Masato|Ishikawa, Daichi|Yamada, Shinichiro|Ikemoto, Tetsuya|Saito, Y U|Imura, Satoru|Shimada, Mitsuo | ||||||||||
| PMID: | 26851035 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncol Rep. 2016 Aug;36(2):853-62. | ||||||||||
| Title: | NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma. | ||||||||||
| Author: | Lin, Shuang|Zhou, Senjun|Jiang, Shaojie|Liu, Xiaolong|Wang, Yifan|Zheng, Xueyong|Zhou, Haimeng|Li, Xuhui|Cai, Xiujun | ||||||||||
| PMID: | 27349376 | ||||||||||
| 9. | |||||||||||
| Journal: | Oncol Rep. 2016 Oct;36(4):2193-9. | ||||||||||
| Title: | Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation. | ||||||||||
| Author: | Wen, Sailan|Liu, Yuwu|Yang, Manyi|Yang, Keda|Huang, Jianghai|Feng, Deyun | ||||||||||
| PMID: | 27509921 | ||||||||||
| 10. | |||||||||||
| Journal: | Int J Cancer. 2017 Apr 1;140(7):1581-1596. | ||||||||||
| Title: | Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. | ||||||||||
| Author: | Wu, Sheng-Ming|Lin, Syuan-Ling|Lee, Kang-Yun|Chuang, Hsiao-Chi|Feng, Po-Hao|Cheng, Wan-Li|Liao, Chia-Jung|Chi, Hsiang-Cheng|Lin, Yang-Hsiang|Tsai, Chung-Ying|Chen, Wei-Jan|Yeh, Chau-Ting|Lin, Kwang-Huei | ||||||||||
| PMID: | 27925179 | ||||||||||
| 11. | |||||||||||
| Journal: | Cancer Genet. 2017 Oct;216-217:37-51. | ||||||||||
| Title: | Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. | ||||||||||
| Author: | Agarwal, Rahul|Narayan, Jitendra|Bhattacharyya, Amitava|Saraswat, Mayank|Tomar, Anil Kumar | ||||||||||
| PMID: | 29025594 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncotarget. 2017 May 5;8(32):52948-52959. | ||||||||||
| Title: | MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma. | ||||||||||
| Author: | Fu, Shun-Jun|Chen, Jian|Ji, Fei|Ju, Wei-Qiang|Zhao, Qiang|Chen, Mao-Gen|Guo, Zhi-Yong|Wu, Lin-Wei|Ma, Yi|Wang, Dong-Ping|Zhu, Xiao-Feng|He, Xiao-Shun | ||||||||||
| PMID: | 28881785 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Biomark. 2017 Jul 19;20(1):101-106. | ||||||||||
| Title: | Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis. | ||||||||||
| Author: | Fu, Luoqin|Liu, Suxia|Wang, Huiju|Ma, Yingyu|Li, Li|He, Xianglei|Mou, Xiaozhou|Tong, Xiangmin|Hu, Zhiming|Ru, Guoqing | ||||||||||
| PMID: | 28759960 | ||||||||||
| 14. | |||||||||||
| Journal: | Oncol Lett. 2017 Mar;13(3):1587-1594. | ||||||||||
| Title: | NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation. | ||||||||||
| Author: | Lai, Xiao-Bo|Nie, Yu-Qiang|Huang, Hong-Li|Li, Ying-Fei|Cao, Chuang-Yu|Yang, Hui|Shen, Bo|Feng, Zhi-Qiang | ||||||||||
| PMID: | 28454295 | ||||||||||
| 15. | |||||||||||
| Journal: | Int J Oncol. 2017 Feb;50(2):405-413. | ||||||||||
| Title: | NEK2 serves as a prognostic biomarker for hepatocellular carcinoma. | ||||||||||
| Author: | Li, Gang|Zhong, Yanping|Shen, Qingrong|Zhou, Yi|Deng, Xiaofang|Li, Cuiping|Chen, Jiagui|Zhou, Ying|He, Min | ||||||||||
| PMID: | 28101574 | ||||||||||
| 16. | |||||||||||
| Journal: | Diagn Pathol. 2017 Jan 13;12(1):4. | ||||||||||
| Title: | A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies. | ||||||||||
| Author: | Wang, Feifei|Wang, Ruliang|Li, Qiuwen|Qu, Xueling|Hao, Yixin|Yang, Jingwen|Zhao, Huixia|Wang, Qian|Li, Guanghui|Zhang, Fengyun|Zhang, He|Zhou, Xuan|Peng, Xioumei|Bian, Yang|Xiao, Wenhua | ||||||||||
| PMID: | 28086821 | ||||||||||
| 17. | |||||||||||
| Journal: | Oncol Rep. 2018 Mar;39(3):1023-1033. | ||||||||||
| Title: | NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition. | ||||||||||
| Author: | Zhang, Yi|Wang, Wei|Wang, Yifei|Huang, Xiaohui|Zhang, Zhaohui|Chen, Bin|Xie, Wenxuan|Li, Shaoqiang|Shen, Shunli|Peng, Baogang | ||||||||||
| PMID: | 29399700 | ||||||||||
| 18. | |||||||||||
| Journal: | Ann Hepatol. 2018 Aug 24;17(5):843-856. | ||||||||||
| Title: | NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection. | ||||||||||
| Author: | Chang, Yu-Ying|Yen, Chia-Jui|Chan, Shih-Huang|Chou, Yi-Wen|Lee, Yun-Ping|Bao, Ching-Yu|Huang, Chien-Jung|Huang, Wenya | ||||||||||
| PMID: | 30145571 | ||||||||||